Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
All India Institute of Medical Sciences, New Delhi Ministry of Science and Technology, India |
---|---|
Information provided by: | All India Institute of Medical Sciences, New Delhi |
ClinicalTrials.gov Identifier: | NCT00698386 |
The primary objective of the study is to evaluate the efficacy of oral Zinc administration in new smear positive pulmonary tuberculosis patients. Evidence is available suggesting that zinc deficiency rapidly diminishes antibody- and cell-mediated immune responses in both humans and animals and renders the individual susceptible to a variety of pathogens. This micronutrient has also been found to be useful in the treatment of lung tuberculosis in limited number of patients.
We are conducting this study in category-I patients (As per World Health Organization, Geneva classification of tuberculosis) having lung tuberculosis to see the efficacy and also to see any change in the immunological parameters.
Condition | Intervention | Phase |
---|---|---|
Pulmonary Tuberculosis |
Dietary Supplement: Zinc supplement Dietary Supplement: Placebo |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study |
Official Title: | Efficacy of Oral Zinc Administration as an Adjunct Therapy in Category I Pulmonary Tuberculosis Along With Assessment of Immunological Parameters (Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial |
Estimated Enrollment: | 150 |
Study Start Date: | February 2008 |
Estimated Study Completion Date: | September 2009 |
Estimated Primary Completion Date: | September 2009 (Final data collection date for primary outcome measure) |
Malnutrition is commonly observed in patients with pulmonary tuberculosis. There are reports claiming patients with active pulmonary tuberculosis are malnourished as indicated by diminished visceral proteins, anthropometric indexes, and micronutrient status. Zinc plays role in protecting cells from the damaging effects of free radicals. Zinc supplementation was shown to prevent pulmonary pathology due to hypoxia-induced lung damage in rats. The role of zinc in faster sputum smear conversion has not yet been studied. However, there are reports which confirms, in vitro cellular killing of tubercle bacilli by macrophages after zinc supplementation.
We are investigating oral zinc supplement for its efficacy in TB patients in a "double-blind placebo-controlled randomized clinical trial" fashion. We are conducting this trial in Category-I pulmonary TB Patients (as per RNTCP, Ministry of Health and Family Welfare, Govt.of India), and are assessing the outcome in the form of clinical improvement, sputum conversion and immunological parameters. This is a multi-centric trial sponsored by the Department of Biotechnology, Ministry of Science and Technology, Govt. of India.
Supplements and placebo have been prepared by Cadila pharmaceutical Ltd., India, in the form of tablets. Each micronutrient tablet contains 50mg zinc (as zinc sulphate) in a lactose matrix. The placebo consisted of lactose alone. Supplement and placebo capsules were indistinguishable in appearance both externally and internally. In this clinical trial one tablet of zinc as oral supplement will be given everyday during the entire course in line with the directly observed treatment, short-course (DOTS) strategy recommended by the World Health Organization.
Ages Eligible for Study: | 18 Years to 60 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Surendra K Sharma, MD,Ph.D | 91-112-659-4415 | surensk@gmail.com, sksharma@aiims.ac.in |
Contact: Alladi Mohan, MD | 91-877-228-7777 ext 2256 | alladimohan@yahoo.com |
India | |
All India Institute of Medcial Sciences- | Recruiting |
New Delhi, India, 110029 | |
Contact: Surendra K Sharma, MD, Ph.D 26-594-415 surensk@gmail.com, sksharma@aiims.ac.in | |
Contact: Alladi Mohan, MD 91-877-228-7777 ext 2256 alladimohan@yahoo.com | |
Principal Investigator: Surendra K Sharma, MD, Ph.D | |
Principal Investigator: Alladi Mohan, MD | |
Sub-Investigator: Depender K Mitra, Ph.D |
Principal Investigator: | Surendra Kumar Sharma | All India Institute of Medical Sciences, New Delhi |
Responsible Party: | All India Institute of Medical Sciences ( Surendra Kumar Sharma ) |
Study ID Numbers: | DTPR7885/Med/141166/06 |
Study First Received: | June 13, 2008 |
Last Updated: | June 16, 2008 |
ClinicalTrials.gov Identifier: | NCT00698386 |
Health Authority: | India: Ministry of Health |
Micronutrient Zinc Category I PTB RNTCP DOTS |
Sputum smear conversion Reduced relapse Immunopathogenesis Category-I |
Bacterial Infections Gram-Positive Bacterial Infections Respiratory Tract Infections Respiratory Tract Diseases Zinc Sulfate Tuberculosis, pulmonary |
Lung Diseases Zinc Tuberculosis, Pulmonary Mycobacterium Infections Tuberculosis |
Growth Substances Physiological Effects of Drugs Trace Elements |
Micronutrients Pharmacologic Actions Actinomycetales Infections |